KALA BIO Inc. (NASDAQ: KALA)
$7.80
-0.0200 ( -0.26% ) 18.3K
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
Market Data
Open
$7.80
Previous close
$7.82
Volume
18.3K
Market cap
$33.20M
Day range
$7.36 - $7.69
52 week range
$4.21 - $15.94
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | May 14, 2024 |
ars | Annual reports | 1 | Apr 29, 2024 |
def | Proxies and info statements | 8 | Apr 29, 2024 |
pre | Proxies and info statements | 8 | Apr 19, 2024 |
10-k | Annual reports | 122 | Mar 29, 2024 |
8-k | 8K-related | 14 | Mar 29, 2024 |
8-k | 8K-related | 18 | Mar 26, 2024 |
8-k | 8K-related | 14 | Mar 04, 2024 |
4 | Insider transactions | 1 | Jan 05, 2024 |
4 | Insider transactions | 1 | Jan 05, 2024 |